<?xml version="1.0" encoding="UTF-8"?>
<bio id="BIO-d7e1978-autogenerated" rid="ath2">
 <p>
  <bold>Alexej Dick</bold> is currently a postdoctoral fellow at Drexel University, Philadelphia, PA, USA. He received his Ph.D. in 2016 at the Max Delbr√ºck Center (MDC) for Molecular Medicine and Free University of Berlin, Germany, in Biochemistry/Structural Biology, working in the Laboratory of Prof. Dr. Oliver Daumke on the Myxovirus resistant protein family (MxA and MxB) and Orthomyxoviruses. After his Ph.D., he joined the group of Dr. Irwin Chaiken at Drexel Univerity, Philadelphia, PA, USA, to study cyclic peptides triazoles, an anti-HIV molecule class interfering with the virus entry/fusion. In 2019, he joined the group of Dr. Simon Cocklin and is currently working in infectious disease-related (HIV-1, Ebola virus, SARS-CoV-2) computationally aided drug design supported by biochemical, virological, molecular biological, and structural methodologies.
 </p>
</bio>
